Defining a Technique for the Use of Cryogenic Catheters for Biopsy and Ablation for the Diagnostic and Treatment of Pulmonary Lesions: An Ex-Vivo Human Lung Model Study. (NCT05948904)

🧪 Interventions in This Study

• Cryo Ex Vivo (DIAGNOSTIC_TEST)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• CHUM — Montreal, Quebec

📞 Contact the Study Coordinator

Phone: (514) 890-8000

Email: moishe.liberman@umontreal.ca

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Lung Diseases

• CF Bronchodilation — Vancouver, British Columbia
• Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers — Tampa, Florida
• Data Collection For Adventitious Lung Sounds Algorithm Using Eko Digital Devices in a Clinical Setting — Forney, Texas
• Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients — Miami, Florida
• Cough Capture as a Portal Into the Lung — The Bronx, New York

Explore by condition: All Lung Diseases clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.